Evidence map›Paper›PMID 41139383›Full record

ArticleSubstance use & addiction journal2026

Envisioning a Humane and Accessible US Methadone Treatment System: Generating Policy and Practice Recommendations From the Liberate Methadone Movement.

Noa Krawczyk, Jordan Scott, Megan Miller, Abby Coulter, Aaron Ferguson, David Frank, Ayana Jordan, Paul Joudrey, Simeon D Kimmel, Ximena A Levander and 9 more

Abstract read
In one paragraph

Article in Substance use & addiction journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Noa KrawczykCenter for Opioid Epidemiology and Policy, NYU Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-7396-3938
Jordan ScottPennsylvania Harm Reduction Network, Philadelphia, PA, USA.
Megan MillerCenter for Opioid Epidemiology and Policy, NYU Grossman School of Medicine, New York, NY, USA.
Abby CoulterMedication Assisted Treatment Support and Awareness, Morgantown, WV, USA.
Aaron FergusonNational Survivors Union, Greensboro, NC, USA.
David FrankDepartment of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, NY, USA.
Ayana JordanDepartment of Population Health, NYU Grossman School of Medicine, New York, NY, USA.
Paul JoudreyDivision of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Simeon D KimmelSection of General Internal Medicine and Infectious Diseases, Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA.
Ximena A LevanderSection of Addiction Medicine, Division of General Internal Medicine and Geriatrics, Department of Medicine, Oregon Health & Science University, Portland, OR, USA.ORCID 0000-0003-4919-7492
Ruth PoteeBehavioral Health Network, Springfield, MA, USA.
Kate E RobertsBryn Mawr College, Graduate School of Social Work and Social Research, Bryn Mawr, PA, USA.
Danielle RussellThe Kirby Institute, University of South Wales (UNSW), Kensington, NSW, Australia.
Rachel SimonDepartment of Psychiatry, NYU Grossman School of Medicine, New York, NY, USA.
Kimberly L SueProgram in Addiction Medicine, Division of General Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Leslie W SuenDivision of General Internal Medicine, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, CA, USA.
Louise VincentNational Survivors Union, Greensboro, NC, USA.
Nicholas VoylesIndiana Recovery Alliance, Bloomington, IN, USA.
Caty SimonWhose Corner is it Anyway, Holyoke, MA, USA.ORCID 0000-0002-5677-297X

Funding

Vanderbilt Oregon COllaborative Scholar Training in Addiction Research (COSTAR)K12DA061526 · NIDA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW S FREIBERG, Philip Todd Korthuis · 2024 to 2026
$1.5M
Liberating methadone: Building a roadmap and community for changeR13DA058520 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JORDAN, AYANA, KRAWCZYK, NOA · 2023 to 2023
$10k
NIDA NIH HHS K12 DA061526NIDA NIH HHS R13 DA058520
6 · The paper itself

Abstract

Methadone treatment (MT) for opioid use disorder saves lives, but the US MT system has long been dominated by punitive policies and practices that make MT inaccessible, burdensome, and traumatic for patients. After generations without changes to methadone regulations, a confluence of circumstance-including the COVID-19 pandemic and an overdose crisis that has taken over a million lives-has begun to shift the MT advocacy and political landscape. This commentary describes the building of the "Liberate Methadone" movement; a grassroots effort led by people with lived and living experience with methadone, addiction clinicians, researchers, community leaders, and people with many of these identities. The Liberate Methadone movement is dedicated to building a more accessible, equitable MT system that prioritizes patient health, promotes dignity, and is grounded in evidence. We describe the experience of planning and hosting a national conference and generating proceedings with recommendations for needed incremental and structural reforms within the US MT system. The lessons learned from this movement can motivate others across clinical, research, and policy roles to partner with and learn from patient and community-led groups, guiding needed reforms within systems of care. It is through these joint efforts and listening to those directly impacted groups who have been left out of the conversation for far too long, that we can successfully reduce overdose and suffering, toward better health, dignity, and thriving in our communities.

Indexed as

Health PolicyHealth Services AccessibilityMethadoneOpiate Substitution TreatmentOpioid-Related DisordersCOVID-19HumansUnited StatesMethadoneadvocacycommunity-engagedgrassrootsmethadoneopioidsoverdose preventionreformtreatment

Identifiers

PMID41139383
PMCPMC12875567

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.